| Small-cell lung cancer JP Van Meerbeeck, DA Fennell, DKM De Ruysscher The Lancet 378 (9804), 1741-1755, 2011 | 1220 | 2011 |
| ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) A Brunelli, A Charloux, CT Bolliger, G Rocco, JP Sculier, G Varela, ... European Respiratory Journal 34 (1), 17-41, 2009 | 902 | 2009 |
| Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M Reck, S Popat, N Reinmuth, D De Ruysscher, KM Kerr, S Peters Annals of oncology 25, iii27-iii39, 2014 | 791 | 2014 |
| Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M Früh, D De Ruysscher, S Popat, L Crinò, S Peters, E Felip Annals of oncology 24, vi99-vi105, 2013 | 696 | 2013 |
| Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up J Vansteenkiste, D De Ruysscher, WEE Eberhardt, E Lim, S Senan, ... Annals of oncology 24, vi89-vi98, 2013 | 641 | 2013 |
| Radiotherapy toxicity D De Ruysscher, G Niedermann, NG Burnet, S Siva, AWM Lee, ... Nature Reviews Disease Primers 5 (1), 13, 2019 | 614 | 2019 |
| The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant K Reynders, T Illidge, S Siva, JY Chang, D De Ruysscher Cancer treatment reviews 41 (6), 503-510, 2015 | 608 | 2015 |
| 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ... Annals of Oncology 25 (8), 1462-1474, 2014 | 538 | 2014 |
| Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach JA Langendijk, P Lambin, D De Ruysscher, J Widder, M Bos, M Verheij Radiotherapy and Oncology 107 (3), 267-273, 2013 | 525 | 2013 |
| European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer D De Ruysscher, C Faivre-Finn, U Nestle, CW Hurkmans, C Le Péchoux, ... Journal of clinical oncology 28 (36), 5301-5310, 2010 | 495* | 2010 |
| Predicting outcomes in radiation oncology—multifactorial decision support systems P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ... Nature reviews Clinical oncology 10 (1), 27-40, 2013 | 449 | 2013 |
| Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer D De Ruysscher, M Pijls-Johannesma, SM Bentzen, A Minken, ... J Clin Oncol 24 (7), 1057-1063, 2006 | 421 | 2006 |
| 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ... Annals of Oncology 26 (8), 1573-1588, 2015 | 405 | 2015 |
| Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis JPC Grutters, AGH Kessels, M Pijls-Johannesma, D De Ruysscher, ... Radiotherapy and Oncology 95 (1), 32-40, 2010 | 402 | 2010 |
| Molecular and translational classifications of DAMPs in immunogenic cell death AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, BS Pedro, J Manuel, ... Frontiers in immunology 6, 169354, 2015 | 392 | 2015 |
| Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures RTHM Larue, G Defraene, D De Ruysscher, P Lambin, W Van Elmpt The British journal of radiology 90 (1070), 20160665, 2017 | 382 | 2017 |
| Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ... Annals of Oncology 25 (9), 1681-1690, 2014 | 361 | 2014 |
| Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non–small-cell lung cancer after … WEE Eberhardt, C Pöttgen, TC Gauler, G Friedel, S Veit, V Heinrich, ... Journal of Clinical Oncology 33 (35), 4194-4201, 2015 | 356 | 2015 |
| Pet-ct–based auto-contouring in non–small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved … A Van Baardwijk, G Bosmans, L Boersma, J Buijsen, S Wanders, ... International Journal of Radiation Oncology* Biology* Physics 68 (3), 771-778, 2007 | 334 | 2007 |
| Radical treatment of non–small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450) D De Ruysscher, R Wanders, A van Baardwijk, AMC Dingemans, ... Journal of Thoracic Oncology 7 (10), 1547-1555, 2012 | 319 | 2012 |
